Russian Ministry of Health order from 09.11.2012 N 742n
Standard of specialized medical care for children with acute viral hepatitis A mild
Age category: children
Floor: any
Phase: acute
Stage: mild
complications: regardless of the complications
Type of medical care: specialized medical care
care conditions: stationary
The form of medical care: emergency
Average treatment time (number of days): 10
Code ICD X * Nosological unit
B15.9 hepatitis A without hepatic coma
1. Medical interventions to diagnose the disease, condition,
Reception (examination, consultation), a specialist doctor | |||
Kodmeditsinskoy services |
Name of medical services |
The average rate of frequency(1) |
The average index of the multiplicity of application |
B01.014.001 |
Reception (examination, consultation), an infectious disease physician primary |
1 |
1 |
B01.028.001 |
Reception (examination, consultation), ENT physician primary |
0,05 |
1 |
B01.029.001 |
Reception (examination, consultation) ophthalmologist primary |
0,05 |
1 |
B01.031.001 |
Reception (examination, consultation) pediatrician primary |
0,5 |
1 |
B01.057.001 |
Reception (examination, consultation) surgeon primary |
0,05 |
1 |
Laboratory Methods | |||
Kodmeditsinskoy services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
A09.05.044 |
Investigation levels of gamma-glutamyltransferase in the blood |
0,3 |
1 |
A09.05.046 |
Investigation of alkaline phosphatase in the blood |
0,01 |
1 |
A09.19.002 |
Fecal culture worms |
1 |
1 |
A26.06.034 |
Determination of antibody class M, G (IgG, IgM) to HAV (Hepatitis A virus) in blood |
1 |
1 |
A26.06.036 |
Determination of antigen to the virus hepatitis B (NBsAg Hepatitis B virus) in blood |
1 |
1 |
A26.06.041 |
Determination of antibody class M, G (IgM, IgG) to viral hepatitis C (Hepatitis Cvirus) in the blood |
1 |
1 |
A26.06.086 |
Determination of antibodies to serovar enterokolitika Yersinia (Yersinia enterocolitica) Blood |
1 |
1 |
A26.19.001 |
Bacteriological examination of feces for the pathogen dysentery (Shigella spp.) |
1 |
1 |
A26.19.002 |
Bacteriological examination of feces for typhoid-parathyphoid microorganisms (Salmonella typhi) |
1 |
1 |
A26.19.003 |
Bacteriological examination of feces for salmonella (Salmonella spp.) |
1 |
1 |
A26.19.004 |
Bacteriological examination of feces for Yersinia (Yersinia spp.) |
1 |
1 |
B03.016.003 |
Total (clinical) blood test detailed |
1 |
1 |
B03.016.004 |
Biochemical analysis of blood Obshcheterapevtichesky |
1 |
1 |
B03.016.006 |
Urinalysis total |
1 |
1 |
B03.016.010 |
scatological study |
1 |
1 |
Instrumental methods of research | |||
Kodmeditsinskoy services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
A04.16.001 |
Ultrasound examination of the abdominal cavity (complex) |
0,2 |
1 |
A05.10.006 |
electrocardiogram |
0,2 |
1 |
A06.09.007 |
radiography |
0,01 |
1 |
A06.30.004 |
Panoramic shot of the abdomen and pelvic organs |
0,01 |
1 |
2. Medical services for the treatment of diseases, conditions and monitor treatment
Reception (examination, consultation) and specialist doctor supervision | |||
Code of medical services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
B01.014.003 |
Daily inspection infectious disease with the supervision and care of middle and junior medical staff in a hospital ward |
1 |
9 |
B01.028.002 |
Reception (examination, consultation), ENT physician re |
0,01 |
1 |
B01.029.002 |
Reception (examination, consultation) ophthalmologist re |
0,01 |
1 |
B01.031.002 |
Reception (examination, consultation) pediatrician re |
0,05 |
1 |
B01.054.001 |
Inspection (consultation) doctor-physiotherapist |
0,5 |
1 |
B01.057.002 |
Reception (examination, consultation) surgeon re |
0,01 |
1 |
Laboratory Methods | |||
Kodmeditsinskoy services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
A09.05.044 |
Investigation levels of gamma-glutamyltransferase in the blood |
0,5 |
1 |
A09.19.001 |
Fecal occult blood test |
0,01 |
1 |
A09.19.002 |
Fecal culture worms |
0,01 |
1 |
A26.06.039 |
Determination of antibody class M, G (IgM, IgG) antigen of hepatitis B (HbcAg Hepatitis B virus) in blood |
0,1 |
1 |
A26.06.041 |
Determination of antibody class M, G (IgM, IgG) to the viral HCV (Hepatitis Cvirus) Blood |
0,05 |
1 |
B03.016.003 |
Total (clinical) blood test detailed |
1 |
1 |
B03.016.004 |
Biochemical analysis of blood Obshcheterapevtichesky |
1 |
1 |
B03.016.006 |
Urinalysis total |
1 |
1 |
B03.016.010 |
scatological study |
1 |
1 |
Instrumental methods of research | |||
Kodmeditsinskoy services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
A03.16.001 |
Esophagogastroduodenoscopy |
0,05 |
1 |
A04.16.001 |
Ultrasound examination of the abdominal cavity (complex) |
0,5 |
1 |
A05.10.006 |
electrocardiogram |
0,05 |
1 |
Drug-free methods of prevention, treatment and medical rehabilitation | |||
Kodmeditsinskoy services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
A17.14.001 |
Electrophoresis drugs for liver and biliary tract |
0,2 |
5 |
A17.30.019 |
Exposure to an alternating magnetic field (AMF) |
0,2 |
5 |
A20.30.027 |
Receiving mineral water |
1 |
30 |
A22.14.002.01 |
Phonophoresis drug for liver and biliary tract |
0,1 |
5 |
3. The list of drugs for medical use, registered on the territory of the Russian Federation, with an indication of the mean daily dose courses
The code |
Anatomical Therapeutic Chemical Classification System |
Name of the drug ** |
The average rate of frequency |
Units |
SSD *** |
SKD **** |
|---|---|---|---|---|---|---|
A02BA |
Blockers H2-histamine receptors |
0,02 |
||||
ranitidine |
mg |
200 |
2000 |
|||
A02BC |
proton pump inhibitors |
0,03 |
||||
omeprazole |
mg |
200 |
2000 |
|||
A02BX |
Other drugs for the treatment of gastric ulcer and duodenal ulcers and gastroesophageal reflux disease |
0,05 |
||||
Bismuth tripotassium dicitratobismuthate |
mg |
40 |
400 |
|||
A03AD |
Papaverine and its derivatives |
1 |
||||
Drotaverinum |
mg |
20 |
200 |
|||
Papaverine |
mg |
60 |
600 |
|||
A05AA |
The formulations of bile acids |
0,2 |
||||
ursodeoxycholic acid |
mg |
250 |
2500 |
|||
A05AX |
Other drugs for the treatment of biliary tract diseases |
0,6 |
||||
Artichoke leaf extract |
g |
0,6 |
6 |
|||
Rosehip extract |
ml |
15 |
150 |
|||
A05BA |
Preparations for the treatment of liver diseases |
0,3 |
||||
Glycyrrhizic acid + Phospholipids |
mg |
35+65 |
350+650 |
|||
A06AD |
Osmotic laxatives |
0,4 |
||||
lactulose |
mg |
7 |
35 |
|||
magnesium sulfate |
mg |
1250 |
12500 |
|||
A07BA |
coal preparations |
0,1 |
||||
Activated carbon |
mg |
5000 |
30000 |
|||
A07BC |
Absorbent intestinal drugs other |
0,4 |
||||
dioctahedral smectite |
mg |
5000 |
20000 |
|||
A07FA |
antidiarrheal microorganisms |
0,5 |
||||
bifidobacteria bifidum |
dose |
15 |
150 |
|||
A09AA |
enzyme preparations |
0,3 |
||||
pancreatin |
ED |
10000 (of lipase) |
50000 (for lipase) |
|||
A11GA |
Ascorbic acid (vitamin C) |
1 |
||||
Vitamin C |
mg |
250 |
2500 |
|||
A11HA |
Other vitamins |
1 |
||||
vitamin E |
mg |
400 |
4000 |
|||
A12AA |
calcium |
0,1 |
||||
calcium gluconate |
g |
6 |
60 |
|||
A16AX |
Other drugs for treating diseases of the gastrointestinal tract and metabolic disorders |
0,1 |
||||
thioctic acid |
mg |
125 |
1250 |
|||
B05BB |
Solutions affecting the water-electrolyte balance |
0,2 |
||||
Potassium chloride + Calcium chloride Magnesium chloride + + + Sodium acetate Sodium chloride |
ml |
500 |
4000 |
|||
sodium chloride complex (chloride Potassium + Calcium chloride + sodium chloride) |
ml |
500 |
4000 |
|||
B05CX |
Other irrigation solutions |
0,1 |
||||
Dextrose |
ml |
500 |
1500 |
|||
B05XA |
electrolyte solutions |
0,1 |
||||
Sodium chloride |
ml |
200 |
1000 |
|||
potassium chloride |
mg |
20 |
200 |
|||
C03CA |
sulfonamides |
0,01 |
||||
furosemide |
mg |
1 |
10 |
|||
D08AG |
iodine preparations |
0,1 |
||||
+ Iodine (potassium iodide + Ethanol) |
ml |
1 |
10 |
|||
J01DB |
Cephalosporins 1st Generation |
0,05 |
||||
cefazolin |
mg |
10 |
100 |
|||
J01DD |
Cephalosporins of third generation |
0,01 |
||||
ceftriaxone |
mg |
1000 |
5000 |
|||
L03AX |
other immunostimulants |
0,01 |
||||
meglumine akridonatsetat |
mg |
250 |
1250 |
|||
M01AE |
Propionic acid |
0,1 |
||||
ibuprofen |
mg |
400 |
2000 |
|||
P01AB |
nitroimidazole derivatives |
0,1 |
||||
metronidazole |
mg |
500 |
5000 |
|||
R06AA |
ethers alkylamines |
|||||
diphenhydramine |
ml |
30 |
300 |
|||
R06AC |
substituted ethylenediamines |
0,05 |
||||
Chloropyramine |
mg |
12,5 |
125 |
|||
R06AE |
piperazine derivatives |
0,11 |
||||
cetirizine |
mg |
12,5 |
125 |
|||
cetirizine |
mg |
10 |
100 |
|||
R06AX |
Other systemic antihistamines |
0,04 |
||||
loratadine |
mg |
10 |
100 |
|||
V07AB |
Solvents and diluents, including irrigation solutions |
1 |
||||
Water for injections |
ml |
10 |
100 |
4. Kinds of medical supplies, including specialized therapeutic food
Name of Clinical Nutrition |
The average rate of frequency |
amount |
|---|---|---|
diet variant with mechanical and chemical schazheniya |
1 |
10 |
* - International Statistical Classification of Diseases and Related Health X review
** - international nonproprietary or chemical name of the drug, and in their absence - the trade name of the drug
*** - average daily dose
**** - average course dose
Remarks:
1. Medicinal products for medical use, registered on the territory of the Russian Federation shall be appointed in accordance with the instructions for use of the drug for medical use and for pharmacotherapeutic group Anatomical Therapeutic Chemical Classification System, recommended by the World Health Organization, as well as the route of administration and application of the drug. When assigning of medicaments for the medical use children dose is determined taking into account the mass body age in accordance with the instructions for use of the drug for medical application.
2. Purpose and use of drugs for medical use, medical devices and specialized clinical nutrition products are not included in the standard of care, allowed in the case of medical indications (individual intolerance, for health reasons) by the decision of the medical commission (Part 5 of Article 37 of the Federal Law of November 21, 2011 № 323-FZ "On the basis of public health protection in the Russian Federation" (Collected Legislation of the Russian Federation, 2011, № 48, Art. 6724; 2012, number 26, Art. 3442, 3446)).
(1) the likelihood of providing medical services or prescribing for medical applications (medical devices) included in the standard of care that can take values from 0 to 1, where 1 indicates that the event is 100% of patients true to the model, and the figures at least 1 - indicated in the medical care of patients the standard percentage, with appropriate medical readings.
